Sort
51,593 grants matching “hepatitis”
IRAKM and Mincle in ALD
$438,058Xiaoxia Li · Cleveland Clinic Lerner Com-Cwru · R01 · FY2015 · AA
IRAKM and Mincle in ALD
$438,058Xiaoxia Li · Cleveland Clinic Lerner Com-Cwru · R01 · FY2019 · AA
IRAKM and Mincle in ALD
$438,058Xiaoxia Li · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · AA
IRAKM and Mincle in ALD
$438,058Xiaoxia Li · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · AA
Liver-islet and intra-islet cross talk in alpha cell hyperplasia and beta cell regeneration
$438,034William L Holland · University Of Utah · R01 · FY2024 · DK
A Randomized Trial of Vaccine Adherence in Young IDU
$438,023Paula J Lum · University Of California, San Francisco · R01 · FY2006 · DA
Combinatorial nanotechnology-based regimens for pancreatic cancer chemoprevention
$438,000Sunil Prabhu · Western University Of Health Sciences · R15 · FY2014 · CA
The role of NK cells in immunodysregulation by hepatitis C virus
$438,000Jonathan P Moorman · East Tennessee State University · R15 · FY2013 · AI
Structural Basis of APOBEC Functions and HIV Restriction
$437,996Xiaojiang S Chen · University Of Southern California · R01 · FY2023 · AI
Peripheralized CB1 antagonists for ALD
$437,968Rangan Maitra · Research Triangle Institute · R01 · FY2015 · AA
QSM to Guide Iron Chelating Therapy in Transfusional Iron Overload
$437,946Yi Wang · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · DK
Mechanisms of Mitochondrial Iron Uptake: New Therapeutic Targets in Hepatotoxicity
$437,938John J Lemasters · Medical University Of South Carolina · R01 · FY2024 · DK
Management/Hepatitis C/HIV-infected and Uninfected IDU's
$437,887Mark Sebastian Sulkowski · Johns Hopkins University · R01 · FY2007 · DA
Interaction of Alcohol and HAART in HIV/AIDS and HIV/AIDS and HCV Coinfection
$437,882Elinore F. McCance-Katz · University Of California, San Francisco · R01 · FY2008 · AA
HBV Capsid Effectors
$437,874Raymond F. Schinazi · Emory University · R01 · FY2022 · AI
Multiparametric ultrasound imaging for early detection of nonalcoholic fatty liver disease
$437,873Kenneth Hoyt · University Of Texas Dallas · R01 · FY2021 · DK
Alcohol and HIV-associated Brain Dysfunction
$437,828Ronald A Cohen · Brown University · P01 · FY2010 · AA
Endonuclease-mediated disruption of latent HSV as curative therapy
$437,792Keith R Jerome · Fred Hutchinson Cancer Research Center · R01 · FY2020 · AI
Structures, Dynamics, and Functions of Membrane Proteins
$437,787Stanley J Opella · University Of California, San Diego · R35 · FY2017 · GM
Diagnosis and Pathobiology of Emerging Enterohepatic Helicobacter spp. in Mice
$437,749James G Fox · Massachusetts Institute Of Technology · R01 · FY2011 · RR
Immune Responses in Acute Hepatitis C Infection
$437,726Hugo R Rosen · University Of Colorado Denver · R01 · FY2010 · DK
Safety, Efficacy, and Mechanisms in American Ginseng in HIV-Related Fatigue
$437,724Adriana S.a. Andrade · Johns Hopkins University · R01 · FY2009 · AT
Endonuclease-mediated disruption of latent HSV as curative therapy
$437,702Keith R Jerome · Fred Hutchinson Cancer Center · R01 · FY2022 · AI
Therapeutic HBV vaccines with glucosidase inhibitors
$437,672Thomas Jefferson University · U01 · FY2002 · AI
Hepatitis Beta Research Network Clinical Center in Pacific Northwest/Alaska
$437,657Robert L Carithers · University Of Washington · U01 · FY2011 · DK